Search > Results
You searched for: EV210305 (EV-TRACK ID)
Showing 1 - 10 of 10
Showing 1 - 10 of 10
Details | EV-TRACK ID | Experiment nr. | Species | Sample type | Separation protocol | First author | Year | EV-METRIC |
---|---|---|---|---|---|---|---|---|
EV210305 | 2/10 | Homo sapiens | urine |
Lectin affinity capture (Lotus tetragonolobus) PEG precipitation |
Isaksson, Gustaf L. | 2021 | 50% | |
Study summaryFull title
All authors
Gustaf Lissel Isaksson, Marie Bodilsen Nielsen, Gitte Rye Hinrichs, Nicoline Valentina Krogstrup, Rikke Zachar, Heidi Stubmark, Per Svenningsen, Kirsten Madsen, Claus Bistrup, Bente Jespersen, CONTEXT Study Group; Henrik Birn, Yaseelan Palarasah, Boye L Jensen
Journal
Am J Physiol Renal Physiol
Abstract
Proteinuria predicts accelerated decline in kidney function in kidney transplant recipients (KTRs). (show more...)
EV-METRIC
50% (86th percentile of all experiments on the same sample type)
Reported
Not reported Not applicable EV-enriched
proteins
Protein analysis: analysis of three or more EV-enriched proteins
non
EV-enriched protein
Protein analysis: assessment of a non-EV-enriched protein
qualitative
and quantitative analysis
Particle analysis: implementation of both qualitative and quantitative methods. For the quantitative method, the reporting of measured EV concentration is expected.
electron
microscopy images
Particle analysis: inclusion of a widefield and close-up electron microscopy image
density
gradient
Separation method: density gradient, at least as validation of results attributed to EVs
EV density
Separation method: reporting of obtained EV density
ultracentrifugation specifics
Separation method: reporting of g-forces, duration and rotor type of ultracentrifugation steps
antibody
specifics
Protein analysis: antibody clone/reference number and dilution
lysate
preparation
Protein analysis: lysis buffer composition
Study dataSample type
urine
Sample origin
Kidney transplant recipient controls
Focus vesicles
extracellular vesicle
Separation protocol
Separation protocol
Lectin affinity capture (Lotus tetragonolobus)
PEG precipitation Protein markers
EV: CD9/ CD63/ TSG101/ AQP2/ C9 neoantigen/ iC3b/C3dg/ CR1/ Podocalyxin/ SGLT2
non-EV: Tamm-Horsfall protein Proteomics
no
Show all info
Study aim
Biomarker/New methodological development
Sample
Species
Homo sapiens
Sample Type
urine
Separation Method
Other
Name other separation method
Lectin affinity capture (Lotus tetragonolobus)
Other
Name other separation method
PEG precipitation
Characterization: Protein analysis
Protein Concentration Method
Not determined
Western Blot
Antibody details provided?
Yes
Antibody dilution provided?
Yes
Lysis buffer provided?
Yes
Detected EV-associated proteins
CD9/ CD63/ TSG101/ C9 neoantigen/ iC3b/C3dg/ SGLT2
Not detected EV-associated proteins
AQP2/ CR1/ Podocalyxin
Not detected contaminants
Tamm-Horsfall protein
Characterization: Lipid analysis
No
|
||||||||
EV210305 | 3/10 | Homo sapiens | urine |
Lectin affinity capture (Dolichus biflorus) PEG precipitation |
Isaksson, Gustaf L. | 2021 | 50% | |
Study summaryFull title
All authors
Gustaf Lissel Isaksson, Marie Bodilsen Nielsen, Gitte Rye Hinrichs, Nicoline Valentina Krogstrup, Rikke Zachar, Heidi Stubmark, Per Svenningsen, Kirsten Madsen, Claus Bistrup, Bente Jespersen, CONTEXT Study Group; Henrik Birn, Yaseelan Palarasah, Boye L Jensen
Journal
Am J Physiol Renal Physiol
Abstract
Proteinuria predicts accelerated decline in kidney function in kidney transplant recipients (KTRs). (show more...)
EV-METRIC
50% (86th percentile of all experiments on the same sample type)
Reported
Not reported Not applicable EV-enriched
proteins
Protein analysis: analysis of three or more EV-enriched proteins
non
EV-enriched protein
Protein analysis: assessment of a non-EV-enriched protein
qualitative
and quantitative analysis
Particle analysis: implementation of both qualitative and quantitative methods. For the quantitative method, the reporting of measured EV concentration is expected.
electron
microscopy images
Particle analysis: inclusion of a widefield and close-up electron microscopy image
density
gradient
Separation method: density gradient, at least as validation of results attributed to EVs
EV density
Separation method: reporting of obtained EV density
ultracentrifugation specifics
Separation method: reporting of g-forces, duration and rotor type of ultracentrifugation steps
antibody
specifics
Protein analysis: antibody clone/reference number and dilution
lysate
preparation
Protein analysis: lysis buffer composition
Study dataSample type
urine
Sample origin
Kidney transplant recipient controls
Focus vesicles
extracellular vesicle
Separation protocol
Separation protocol
Lectin affinity capture (Dolichus biflorus)
PEG precipitation Protein markers
EV: CD9/ CD63/ TSG101/ AQP2/ C9 neoantigen/ iC3b/C3dg/ CR1/ Podocalyxin/ SGLT2
non-EV: Tamm-Horsfall protein Proteomics
no
Show all info
Study aim
Biomarker/New methodological development
Sample
Species
Homo sapiens
Sample Type
urine
Separation Method
Other
Name other separation method
Lectin affinity capture (Dolichus biflorus)
Other
Name other separation method
PEG precipitation
Characterization: Protein analysis
Protein Concentration Method
Not determined
Western Blot
Antibody details provided?
Yes
Antibody dilution provided?
Yes
Lysis buffer provided?
Yes
Detected EV-associated proteins
CD9/ CD63/ TSG101/ AQP2/ C9 neoantigen/ iC3b/C3dg/ SGLT2
Not detected EV-associated proteins
CR1/ Podocalyxin
Detected contaminants
Tamm-Horsfall protein
Characterization: Lipid analysis
No
|
||||||||
EV210305 | 7/10 | Homo sapiens | urine |
Lectin affinity capture (Lotus tetragonolobus) PEG precipitation |
Isaksson, Gustaf L. | 2021 | 50% | |
Study summaryFull title
All authors
Gustaf Lissel Isaksson, Marie Bodilsen Nielsen, Gitte Rye Hinrichs, Nicoline Valentina Krogstrup, Rikke Zachar, Heidi Stubmark, Per Svenningsen, Kirsten Madsen, Claus Bistrup, Bente Jespersen, CONTEXT Study Group; Henrik Birn, Yaseelan Palarasah, Boye L Jensen
Journal
Am J Physiol Renal Physiol
Abstract
Proteinuria predicts accelerated decline in kidney function in kidney transplant recipients (KTRs). (show more...)
EV-METRIC
50% (86th percentile of all experiments on the same sample type)
Reported
Not reported Not applicable EV-enriched
proteins
Protein analysis: analysis of three or more EV-enriched proteins
non
EV-enriched protein
Protein analysis: assessment of a non-EV-enriched protein
qualitative
and quantitative analysis
Particle analysis: implementation of both qualitative and quantitative methods. For the quantitative method, the reporting of measured EV concentration is expected.
electron
microscopy images
Particle analysis: inclusion of a widefield and close-up electron microscopy image
density
gradient
Separation method: density gradient, at least as validation of results attributed to EVs
EV density
Separation method: reporting of obtained EV density
ultracentrifugation specifics
Separation method: reporting of g-forces, duration and rotor type of ultracentrifugation steps
antibody
specifics
Protein analysis: antibody clone/reference number and dilution
lysate
preparation
Protein analysis: lysis buffer composition
Study dataSample type
urine
Sample origin
Kidney transplant albuminuria
Focus vesicles
extracellular vesicle
Separation protocol
Separation protocol
Lectin affinity capture (Lotus tetragonolobus)
PEG precipitation Protein markers
EV: CD9/ CD63/ TSG101/ AQP2/ C9 neoantigen/ iC3b/C3dg/ CR1/ Podocalyxin/ SGLT2
non-EV: Tamm-Horsfall protein Proteomics
no
Show all info
Study aim
Biomarker/New methodological development
Sample
Species
Homo sapiens
Sample Type
urine
Separation Method
Other
Name other separation method
Lectin affinity capture (Lotus tetragonolobus)
Other
Name other separation method
PEG precipitation
Characterization: Protein analysis
Protein Concentration Method
Not determined
Western Blot
Antibody details provided?
Yes
Antibody dilution provided?
Yes
Lysis buffer provided?
Yes
Detected EV-associated proteins
CD9/ CD63/ TSG101/ C9 neoantigen/ iC3b/C3dg/ SGLT2
Not detected EV-associated proteins
AQP2/ CR1/ Podocalyxin
Not detected contaminants
Tamm-Horsfall protein
Characterization: Lipid analysis
No
|
||||||||
EV210305 | 8/10 | Homo sapiens | urine |
Lectin affinity capture (Dolichus biflorus) PEG precipitation |
Isaksson, Gustaf L. | 2021 | 50% | |
Study summaryFull title
All authors
Gustaf Lissel Isaksson, Marie Bodilsen Nielsen, Gitte Rye Hinrichs, Nicoline Valentina Krogstrup, Rikke Zachar, Heidi Stubmark, Per Svenningsen, Kirsten Madsen, Claus Bistrup, Bente Jespersen, CONTEXT Study Group; Henrik Birn, Yaseelan Palarasah, Boye L Jensen
Journal
Am J Physiol Renal Physiol
Abstract
Proteinuria predicts accelerated decline in kidney function in kidney transplant recipients (KTRs). (show more...)
EV-METRIC
50% (86th percentile of all experiments on the same sample type)
Reported
Not reported Not applicable EV-enriched
proteins
Protein analysis: analysis of three or more EV-enriched proteins
non
EV-enriched protein
Protein analysis: assessment of a non-EV-enriched protein
qualitative
and quantitative analysis
Particle analysis: implementation of both qualitative and quantitative methods. For the quantitative method, the reporting of measured EV concentration is expected.
electron
microscopy images
Particle analysis: inclusion of a widefield and close-up electron microscopy image
density
gradient
Separation method: density gradient, at least as validation of results attributed to EVs
EV density
Separation method: reporting of obtained EV density
ultracentrifugation specifics
Separation method: reporting of g-forces, duration and rotor type of ultracentrifugation steps
antibody
specifics
Protein analysis: antibody clone/reference number and dilution
lysate
preparation
Protein analysis: lysis buffer composition
Study dataSample type
urine
Sample origin
Kidney transplant albuminuria
Focus vesicles
extracellular vesicle
Separation protocol
Separation protocol
Lectin affinity capture (Dolichus biflorus)
PEG precipitation Protein markers
EV: CD9/ CD63/ TSG101/ AQP2/ C9 neoantigen/ iC3b/C3dg/ CR1/ Podocalyxin/ SGLT2
non-EV: Tamm-Horsfall protein Proteomics
no
Show all info
Study aim
Biomarker/New methodological development
Sample
Species
Homo sapiens
Sample Type
urine
Separation Method
Other
Name other separation method
Lectin affinity capture (Dolichus biflorus)
Other
Name other separation method
PEG precipitation
Characterization: Protein analysis
Protein Concentration Method
Not determined
Western Blot
Antibody details provided?
Yes
Antibody dilution provided?
Yes
Lysis buffer provided?
Yes
Detected EV-associated proteins
CD9/ CD63/ TSG101/ AQP2/ C9 neoantigen/ iC3b/C3dg/ SGLT2
Not detected EV-associated proteins
CR1/ Podocalyxin
Detected contaminants
Tamm-Horsfall protein
Characterization: Lipid analysis
No
|
||||||||
EV210305 | 9/10 | Homo sapiens | urine |
IAF PEG precipitation |
Isaksson, Gustaf L. | 2021 | 50% | |
Study summaryFull title
All authors
Gustaf Lissel Isaksson, Marie Bodilsen Nielsen, Gitte Rye Hinrichs, Nicoline Valentina Krogstrup, Rikke Zachar, Heidi Stubmark, Per Svenningsen, Kirsten Madsen, Claus Bistrup, Bente Jespersen, CONTEXT Study Group; Henrik Birn, Yaseelan Palarasah, Boye L Jensen
Journal
Am J Physiol Renal Physiol
Abstract
Proteinuria predicts accelerated decline in kidney function in kidney transplant recipients (KTRs). (show more...)
EV-METRIC
50% (86th percentile of all experiments on the same sample type)
Reported
Not reported Not applicable EV-enriched
proteins
Protein analysis: analysis of three or more EV-enriched proteins
non
EV-enriched protein
Protein analysis: assessment of a non-EV-enriched protein
qualitative
and quantitative analysis
Particle analysis: implementation of both qualitative and quantitative methods. For the quantitative method, the reporting of measured EV concentration is expected.
electron
microscopy images
Particle analysis: inclusion of a widefield and close-up electron microscopy image
density
gradient
Separation method: density gradient, at least as validation of results attributed to EVs
EV density
Separation method: reporting of obtained EV density
ultracentrifugation specifics
Separation method: reporting of g-forces, duration and rotor type of ultracentrifugation steps
antibody
specifics
Protein analysis: antibody clone/reference number and dilution
lysate
preparation
Protein analysis: lysis buffer composition
Study dataSample type
urine
Sample origin
Kidney transplant albuminuria
Focus vesicles
extracellular vesicle
Separation protocol
Separation protocol
Immunoaffinity capture (non-commercial)
PEG precipitation Protein markers
EV: C9 neoantigen/ iC3b/C3dg/ CD63/ TSG101/ SGLT2
non-EV: None Proteomics
no
Show all info
Study aim
Biomarker/New methodological development
Sample
Species
Homo sapiens
Sample Type
urine
Separation Method
Immunoaffinity capture
Selected surface protein(s)
Complement factor C3dg
Other
Name other separation method
PEG precipitation
Characterization: Protein analysis
Protein Concentration Method
Not determined
Western Blot
Antibody details provided?
Yes
Antibody dilution provided?
Yes
Lysis buffer provided?
Yes
Detected EV-associated proteins
C9 neoantigen/ iC3b/C3dg/ SGLT2
Not detected EV-associated proteins
CD63/ TSG101
Characterization: Lipid analysis
No
|
||||||||
EV210305 | 1/10 | Homo sapiens | urine | (d)(U)C | Isaksson, Gustaf L. | 2021 | 44% | |
Study summaryFull title
All authors
Gustaf Lissel Isaksson, Marie Bodilsen Nielsen, Gitte Rye Hinrichs, Nicoline Valentina Krogstrup, Rikke Zachar, Heidi Stubmark, Per Svenningsen, Kirsten Madsen, Claus Bistrup, Bente Jespersen, CONTEXT Study Group; Henrik Birn, Yaseelan Palarasah, Boye L Jensen
Journal
Am J Physiol Renal Physiol
Abstract
Proteinuria predicts accelerated decline in kidney function in kidney transplant recipients (KTRs). (show more...)
EV-METRIC
44% (80th percentile of all experiments on the same sample type)
Reported
Not reported Not applicable EV-enriched
proteins
Protein analysis: analysis of three or more EV-enriched proteins
non
EV-enriched protein
Protein analysis: assessment of a non-EV-enriched protein
qualitative
and quantitative analysis
Particle analysis: implementation of both qualitative and quantitative methods. For the quantitative method, the reporting of measured EV concentration is expected.
electron
microscopy images
Particle analysis: inclusion of a widefield and close-up electron microscopy image
density
gradient
Separation method: density gradient, at least as validation of results attributed to EVs
EV density
Separation method: reporting of obtained EV density
ultracentrifugation specifics
Separation method: reporting of g-forces, duration and rotor type of ultracentrifugation steps
antibody
specifics
Protein analysis: antibody clone/reference number and dilution
lysate
preparation
Protein analysis: lysis buffer composition
Study dataSample type
urine
Sample origin
Kidney transplant recipient controls
Focus vesicles
extracellular vesicle
Separation protocol
Separation protocol
(Differential) (ultra)centrifugation
Protein markers
EV: CD63/ C9 neoantigen
non-EV: None Proteomics
no
Show all info
Study aim
Biomarker/New methodological development
Sample
Species
Homo sapiens
Sample Type
urine
Separation Method
(Differential) (ultra)centrifugation
dUC: centrifugation steps
Equal to or above 150,000 g
Pelleting performed
Yes
Pelleting: time(min)
100
Pelleting: rotor type
Type 70-Ti
Pelleting: speed (g)
220,000
Characterization: Protein analysis
Protein Concentration Method
Not determined
Western Blot
Antibody details provided?
Yes
Antibody dilution provided?
Yes
Lysis buffer provided?
Yes
Detected EV-associated proteins
CD63/ C9 neoantigen
Characterization: Lipid analysis
No
|
||||||||
EV210305 | 6/10 | Homo sapiens | urine | (d)(U)C | Isaksson, Gustaf L. | 2021 | 44% | |
Study summaryFull title
All authors
Gustaf Lissel Isaksson, Marie Bodilsen Nielsen, Gitte Rye Hinrichs, Nicoline Valentina Krogstrup, Rikke Zachar, Heidi Stubmark, Per Svenningsen, Kirsten Madsen, Claus Bistrup, Bente Jespersen, CONTEXT Study Group; Henrik Birn, Yaseelan Palarasah, Boye L Jensen
Journal
Am J Physiol Renal Physiol
Abstract
Proteinuria predicts accelerated decline in kidney function in kidney transplant recipients (KTRs). (show more...)
EV-METRIC
44% (80th percentile of all experiments on the same sample type)
Reported
Not reported Not applicable EV-enriched
proteins
Protein analysis: analysis of three or more EV-enriched proteins
non
EV-enriched protein
Protein analysis: assessment of a non-EV-enriched protein
qualitative
and quantitative analysis
Particle analysis: implementation of both qualitative and quantitative methods. For the quantitative method, the reporting of measured EV concentration is expected.
electron
microscopy images
Particle analysis: inclusion of a widefield and close-up electron microscopy image
density
gradient
Separation method: density gradient, at least as validation of results attributed to EVs
EV density
Separation method: reporting of obtained EV density
ultracentrifugation specifics
Separation method: reporting of g-forces, duration and rotor type of ultracentrifugation steps
antibody
specifics
Protein analysis: antibody clone/reference number and dilution
lysate
preparation
Protein analysis: lysis buffer composition
Study dataSample type
urine
Sample origin
Kidney transplant albuminuria
Focus vesicles
extracellular vesicle
Separation protocol
Separation protocol
(Differential) (ultra)centrifugation
Protein markers
EV: CD63/ C9 neoantigen
non-EV: None Proteomics
no
Show all info
Study aim
Biomarker/New methodological development
Sample
Species
Homo sapiens
Sample Type
urine
Separation Method
(Differential) (ultra)centrifugation
dUC: centrifugation steps
Equal to or above 150,000 g
Pelleting performed
Yes
Pelleting: time(min)
100
Pelleting: rotor type
Type 70-Ti
Pelleting: speed (g)
220000
Characterization: Protein analysis
Protein Concentration Method
Not determined
Western Blot
Antibody details provided?
Yes
Antibody dilution provided?
Yes
Lysis buffer provided?
Yes
Detected EV-associated proteins
CD63/ C9 neoantigen
Characterization: Lipid analysis
No
|
||||||||
EV210305 | 4/10 | Homo sapiens | urine |
IAF PEG precipitation |
Isaksson, Gustaf L. | 2021 | 38% | |
Study summaryFull title
All authors
Gustaf Lissel Isaksson, Marie Bodilsen Nielsen, Gitte Rye Hinrichs, Nicoline Valentina Krogstrup, Rikke Zachar, Heidi Stubmark, Per Svenningsen, Kirsten Madsen, Claus Bistrup, Bente Jespersen, CONTEXT Study Group; Henrik Birn, Yaseelan Palarasah, Boye L Jensen
Journal
Am J Physiol Renal Physiol
Abstract
Proteinuria predicts accelerated decline in kidney function in kidney transplant recipients (KTRs). (show more...)
EV-METRIC
38% (73rd percentile of all experiments on the same sample type)
Reported
Not reported Not applicable EV-enriched
proteins
Protein analysis: analysis of three or more EV-enriched proteins
non
EV-enriched protein
Protein analysis: assessment of a non-EV-enriched protein
qualitative
and quantitative analysis
Particle analysis: implementation of both qualitative and quantitative methods. For the quantitative method, the reporting of measured EV concentration is expected.
electron
microscopy images
Particle analysis: inclusion of a widefield and close-up electron microscopy image
density
gradient
Separation method: density gradient, at least as validation of results attributed to EVs
EV density
Separation method: reporting of obtained EV density
ultracentrifugation specifics
Separation method: reporting of g-forces, duration and rotor type of ultracentrifugation steps
antibody
specifics
Protein analysis: antibody clone/reference number and dilution
lysate
preparation
Protein analysis: lysis buffer composition
Study dataSample type
urine
Sample origin
Kidney transplant recipients controls
Focus vesicles
extracellular vesicle
Separation protocol
Separation protocol
Immunoaffinity capture (non-commercial)
PEG precipitation Protein markers
EV: C9 neoantigen/ iC3b/C3dg/ CD63/ TSG101/ SGLT2
non-EV: None Proteomics
no
Show all info
Study aim
Biomarker/New methodological development
Sample
Species
Homo sapiens
Sample Type
urine
Separation Method
Immunoaffinity capture
Selected surface protein(s)
Complement factor C3dg
Other
Name other separation method
PEG precipitation
Characterization: Protein analysis
Protein Concentration Method
Not determined
Western Blot
Antibody details provided?
Yes
Antibody dilution provided?
Yes
Lysis buffer provided?
Yes
Detected EV-associated proteins
C9 neoantigen/ iC3b/C3dg/ SGLT2
Not detected EV-associated proteins
CD63/ TSG101
Characterization: Lipid analysis
No
|
||||||||
EV210305 | 5/10 | Homo sapiens | urine |
IAF PEG precipitation |
Isaksson, Gustaf L. | 2021 | 38% | |
Study summaryFull title
All authors
Gustaf Lissel Isaksson, Marie Bodilsen Nielsen, Gitte Rye Hinrichs, Nicoline Valentina Krogstrup, Rikke Zachar, Heidi Stubmark, Per Svenningsen, Kirsten Madsen, Claus Bistrup, Bente Jespersen, CONTEXT Study Group; Henrik Birn, Yaseelan Palarasah, Boye L Jensen
Journal
Am J Physiol Renal Physiol
Abstract
Proteinuria predicts accelerated decline in kidney function in kidney transplant recipients (KTRs). (show more...)
EV-METRIC
38% (73rd percentile of all experiments on the same sample type)
Reported
Not reported Not applicable EV-enriched
proteins
Protein analysis: analysis of three or more EV-enriched proteins
non
EV-enriched protein
Protein analysis: assessment of a non-EV-enriched protein
qualitative
and quantitative analysis
Particle analysis: implementation of both qualitative and quantitative methods. For the quantitative method, the reporting of measured EV concentration is expected.
electron
microscopy images
Particle analysis: inclusion of a widefield and close-up electron microscopy image
density
gradient
Separation method: density gradient, at least as validation of results attributed to EVs
EV density
Separation method: reporting of obtained EV density
ultracentrifugation specifics
Separation method: reporting of g-forces, duration and rotor type of ultracentrifugation steps
antibody
specifics
Protein analysis: antibody clone/reference number and dilution
lysate
preparation
Protein analysis: lysis buffer composition
Study dataSample type
urine
Sample origin
Kidney transplant recipients controls
Focus vesicles
extracellular vesicle
Separation protocol
Separation protocol
Immunoaffinity capture (non-commercial)
PEG precipitation Protein markers
EV: C9 neoantigen/ CD63/ TSG101/ SGLT2
non-EV: None Proteomics
no
Show all info
Study aim
Biomarker/New methodological development
Sample
Species
Homo sapiens
Sample Type
urine
Separation Method
Immunoaffinity capture
Selected surface protein(s)
Complement factor C9
Other
Name other separation method
PEG precipitation
Characterization: Protein analysis
Protein Concentration Method
Not determined
Western Blot
Antibody details provided?
Yes
Antibody dilution provided?
Yes
Lysis buffer provided?
Yes
Detected EV-associated proteins
C9 neoantigen/ CD63/ SGLT2
Not detected EV-associated proteins
TSG101
Characterization: Lipid analysis
No
|
||||||||
EV210305 | 10/10 | Homo sapiens | urine |
IAF PEG precipitation |
Isaksson, Gustaf L. | 2021 | 38% | |
Study summaryFull title
All authors
Gustaf Lissel Isaksson, Marie Bodilsen Nielsen, Gitte Rye Hinrichs, Nicoline Valentina Krogstrup, Rikke Zachar, Heidi Stubmark, Per Svenningsen, Kirsten Madsen, Claus Bistrup, Bente Jespersen, CONTEXT Study Group; Henrik Birn, Yaseelan Palarasah, Boye L Jensen
Journal
Am J Physiol Renal Physiol
Abstract
Proteinuria predicts accelerated decline in kidney function in kidney transplant recipients (KTRs). (show more...)
EV-METRIC
38% (73rd percentile of all experiments on the same sample type)
Reported
Not reported Not applicable EV-enriched
proteins
Protein analysis: analysis of three or more EV-enriched proteins
non
EV-enriched protein
Protein analysis: assessment of a non-EV-enriched protein
qualitative
and quantitative analysis
Particle analysis: implementation of both qualitative and quantitative methods. For the quantitative method, the reporting of measured EV concentration is expected.
electron
microscopy images
Particle analysis: inclusion of a widefield and close-up electron microscopy image
density
gradient
Separation method: density gradient, at least as validation of results attributed to EVs
EV density
Separation method: reporting of obtained EV density
ultracentrifugation specifics
Separation method: reporting of g-forces, duration and rotor type of ultracentrifugation steps
antibody
specifics
Protein analysis: antibody clone/reference number and dilution
lysate
preparation
Protein analysis: lysis buffer composition
Study dataSample type
urine
Sample origin
Kidney transplant albuminuria
Focus vesicles
extracellular vesicle
Separation protocol
Separation protocol
Immunoaffinity capture (non-commercial)
PEG precipitation Protein markers
EV: C9 neoantigen/ CD63/ TSG101/ SGLT2
non-EV: None Proteomics
no
Show all info
Study aim
Biomarker/New methodological development
Sample
Species
Homo sapiens
Sample Type
urine
Separation Method
Immunoaffinity capture
Selected surface protein(s)
Complement factor C9
Other
Name other separation method
PEG precipitation
Characterization: Protein analysis
Protein Concentration Method
Not determined
Western Blot
Antibody details provided?
Yes
Antibody dilution provided?
Yes
Lysis buffer provided?
Yes
Detected EV-associated proteins
C9 neoantigen/ CD63/ SGLT2
Not detected EV-associated proteins
TSG101
Characterization: Lipid analysis
No
|
||||||||
1 - 10 of 10 |
EV-TRACK ID | EV210305 | |||||||||
---|---|---|---|---|---|---|---|---|---|---|
species | Homo sapiens | |||||||||
sample type | urine | |||||||||
condition | Kidney transplant recipient controls | Kidney transplant recipient controls | Kidney transplant albuminuria | Kidney transplant albuminuria | Kidney transplant albuminuria | Kidney transplant recipient controls | Kidney transplant albuminuria | Kidney transplant recipients controls | Kidney transplant recipients controls | Kidney transplant albuminuria |
separation protocol | Lectin affinity capture (Lotus tetragonolobus)/ PEG precipitation | Lectin affinity capture (Dolichus biflorus)/ PEG precipitation | Lectin affinity capture (Lotus tetragonolobus)/ PEG precipitation | Lectin affinity capture (Dolichus biflorus)/ PEG precipitation | IAF capture (non-commercial)/ PEG precipitation | dUC | dUC | IAF capture (non-commercial)/ PEG precipitation | IAF capture (non-commercial)/ PEG precipitation | IAF capture (non-commercial)/ PEG precipitation |
Exp. nr. | 2 | 3 | 7 | 8 | 9 | 1 | 6 | 4 | 5 | 10 |
EV-METRIC % | 50 | 50 | 50 | 50 | 50 | 44 | 44 | 38 | 38 | 38 |